An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis

NCT05858047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Effects, Drug Side

Interventions

DRUG: Placebo
DRUG: SYHX1901

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.